Detalhe da pesquisa
1.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738257
2.
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering.
Rheumatology (Oxford)
; 61(6): 2398-2412, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636846
3.
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Rheumatology (Oxford)
; 60(12): 5549-5559, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748831
4.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665497
5.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431486
6.
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictors.
Rheumatology (Oxford)
; 58(1): 110-119, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169706
7.
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 58(5): 874-883, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590790
8.
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - relationship with the reason for withdrawal from the previous treatment.
Joint Bone Spine
; 91(4): 105729, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582359
9.
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.
RMD Open
; 8(2)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549857
10.
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
Arthritis Res Ther
; 23(1): 48, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33522948
11.
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.
RMD Open
; 6(3)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950963
12.
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.
J Rheumatol
; 44(12): 1889-1893, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765250